Giant cell tumor of bone following denosumab treatment: assessment of tumor response using various imaging modalities
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-4101
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Giant cell tumor of bone following denosumab treatment: assessment of tumor response using various imaging modalities ; volume:11 ; number:1 ; day:27 ; month:2 ; year:2020 ; pages:1-6 ; date:12.2020
Insights into imaging ; 11, Heft 1 (27.2.2020), 1-6, 12.2020
- Urheber
-
Alothman, Maram
Althobaity, Waleed
Asiri, Yasser
Alreshoodi, Saleh
Alismail, Khalid
Alshaalan, Meshal
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13244-020-00845-y
- URN
-
urn:nbn:de:101:1-2020052207255330788383
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Alothman, Maram
- Althobaity, Waleed
- Asiri, Yasser
- Alreshoodi, Saleh
- Alismail, Khalid
- Alshaalan, Meshal
- SpringerLink (Online service)
Ähnliche Objekte (12)
Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab
Post-Denosumab-Treated Giant Cell Tumor of Bone: A Retrospective Histomorphological and Immunohistochemical Study
The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone
Giant Proliferating Trichilemmal Tumor
Risks and benefits of combining denosumab and surgery in giant cell tumor of bone—a case series
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Radiologic and clinical changes after denosumab treatment for giant cell tumors of the mobile spine: a quantitative study
Correlating the treatment outcome with tumor staging, grading, and various treatment modalities in patients with esthesioneuroblastoma
Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius
Innovative therapy modalities for solid EpCAM-positive tumors
Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab
Post-Denosumab-Treated Giant Cell Tumor of Bone: A Retrospective Histomorphological and Immunohistochemical Study
The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone
Giant Proliferating Trichilemmal Tumor
Risks and benefits of combining denosumab and surgery in giant cell tumor of bone—a case series
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Radiologic and clinical changes after denosumab treatment for giant cell tumors of the mobile spine: a quantitative study
Correlating the treatment outcome with tumor staging, grading, and various treatment modalities in patients with esthesioneuroblastoma
Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius
Innovative therapy modalities for solid EpCAM-positive tumors
Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab
Post-Denosumab-Treated Giant Cell Tumor of Bone: A Retrospective Histomorphological and Immunohistochemical Study
The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone
Giant Proliferating Trichilemmal Tumor
Risks and benefits of combining denosumab and surgery in giant cell tumor of bone—a case series
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Radiologic and clinical changes after denosumab treatment for giant cell tumors of the mobile spine: a quantitative study
Correlating the treatment outcome with tumor staging, grading, and various treatment modalities in patients with esthesioneuroblastoma
Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius